Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, announced the initiation of its FORWARD study, an ...
Penumbra, Inc. announced the initiation of its FORWARD study, which will collect safety and efficacy data on mechanical ...
Latest analysis of Imperative Care’s SYMPHONY-PE trial suggests early thrombectomy may improve key measures of heart recovery in intermediate-risk PE.
Penumbra expands clinical research through the FORWARD stroke study while remaining part of the NYSE Composite with advanced ...
Dr. Fawaz Al-Mufti and team performing a life-saving thrombectomy to restore blood flow to a patient's brain. If you suspect a stroke, get to the hospital immediately-quick action can mean the ...
In a new randomized trial that investigated the question of whether thrombolysis can be omitted for stroke patients undergoing endovascular thrombectomy for a large-vessel occlusion, results were ...
Penumbra, which is set to become part of Boston Scientific this year, is running the trial to inform the treatment of a type of medium-vessel blockage.
A flat 0° head positioning before thrombectomy was associated with a significantly less risk for early neurologic deterioration and all-cause mortality than a conventional 30° head elevation in adults ...
The use of manual aspiration thrombectomy in primary PCI for STEMI has declined significantly since 2011, according to a new analysis of National Cardiovascular Data Registry (NCDR) CathPCI numbers.
Blood pressure management after thrombectomy for acute ischemic stroke may require a change in approach. The HOPE clinical trial—short for Hemodynamic Optimization of Cerebral Perfusion after ...
MedPage Today on MSN
Aspects fails to reflect ceiling for endovascular stroke therapy benefit
Quantitative volumetry better avoids futile reperfusion, per a nationwide study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results